- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ribocyclib, fulvestrant, triptorelin
Total 761 results
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
IpsenCompletedDeep Infiltrating Endometriosis (DIE)China
-
Universitair Ziekenhuis BrusselCompletedInfertility | Poor Ovarian ResponseBelgium
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Centre Hospitalier Universitaire Ibn RochdCompleted
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Georgetown UniversityMedstar Health Research Institute; Breast Cancer Research Foundation; Georgetown-Howard...TerminatedBreast CancerUnited States
-
Antalya IVFWithdrawnPregnancy | Ovarian Hyperstimulation SyndromeTurkey
-
UNICANCERIpsenActive, not recruiting
-
IpsenCompletedPrecocious PubertyFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustIpsenCompletedEndometriosisUnited Kingdom
-
Vietnam National UniversityMerck Sharp & Dohme LLC; Aarhus University Hospital; University of Southern Denmark and other collaboratorsCompleted
-
Children's Hospital Medical Center, CincinnatiWatson PharmaceuticalsCompletedSystemic Lupus ErythematosusUnited States, Brazil
-
IpsenCompleted
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Novartis PharmaceuticalsRecruitingBreast CancerRussian Federation
-
Roswell Park Cancer InstituteCompleted
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Portugal, Spain, Taiwan, Costa Rica, New Zealand, Poland, Chile, Colombia, Guatemala, Israel, Hungary, India, Thailand
-
National Taiwan University HospitalDebiopharm International SA; Ministry of Health and WelfareNot yet recruitingTriple Negative Breast Cancer | Premenopausal Breast Cancer
-
Fudan UniversityActive, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Watson PharmaceuticalsCompletedProstate CancerUnited States
-
Sun Yat-sen UniversityAstraZenecaUnknown
-
Zhejiang Cancer HospitalRecruitingBreast Neoplasm FemaleChina
-
European Organisation for Research and Treatment...Breast International GroupTerminatedBreast CancerUnited Kingdom
-
IpsenCompleted
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
Liaoning Tumor Hospital & InstituteNot yet recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingBreast Cancer | Breast Cancer FemaleChina
-
Novartis PharmaceuticalsRecruiting
-
Sun Yat-sen UniversityRecruiting
-
UNICANCERTerminated
-
M.D. Anderson Cancer CenterBayerActive, not recruitingOvarian Cancer | Endometrial CancerUnited States
-
AstraZenecaNot yet recruiting
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
University of PretoriaWithdrawnDietary Supplements | Bleeding Tendency; Due to Coagulation Defect
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland, Belgium
-
Ain Shams UniversityCompleted
-
American University of Beirut Medical CenterCompleted
-
Tehran University of Medical SciencesCompletedInfertilityIran, Islamic Republic of
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
Kashiv BioSciences, LLCCompletedMetastatic Breast CancerJordan
-
Roswell Park Cancer InstituteTerminated
-
Melanoma Institute AustraliaNovartisRecruiting
-
University of Colorado, DenverUnited States Department of DefenseCompleted